ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • Search
  • My Favorites
    • View and print all favorites
    • Clear all favorites

Abstract Number: 1898

Repression Of Wolf-Hischhorn Syndrome Candidate-1 (WHSC1) Contributes To The Osteoarthritis-Inducing Cartilage Loss Of Functions

Francisco Espinoza1, Yves-Marie Pers2, Paul Chuchana3, Jean Marc Brondello4 and Christian Jorgensen2, 1INSERM U844, MONTPELLIER, France, 2Department of therapy & Immuno-Rhumatology, Inserm U844, CHU saint-Eloi, Université Montpellier 1, CHU Lapeyronie, Montpellier, France, 3INSERM U844, Montpellier, France, 4Inserm U844, UM1, Montpellier, France

Meeting: ACR/ARHP Annual Meeting 2013

Keywords: cartilage, epigenetics and osteoarthritis, Senescent Cells

  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print
Session Information

Title: Genetics and Genomics of Rheumatic Disease II

Session Type: Abstract Submissions (ACR)

Background/Purpose: Accumulation of senescent p16INK4A-positive cells within numerous tissues through out life span contributes to the onset of several age-related disease such as intervertebral disc degenerescence or osteoarthritis (OA). These cells are believed to induce tissue degenerescence and age-dependent loss of functions through the establishment of one senescence-associated secretory phenotype (SASP) including pro-inflammatory cytokines (e.g IL-6, IL-8) and hypertrophic-associated matrix degrading enzymes (e.g MMP1/13 and ADAMTS5). Understanding the molecular mechanism in particular epigenetic regulators leading to the establishment of such deleterious secretome, is a next challenge. Here, we investigate the role and the regulation of the histone H3K36Me2 methyltranferase, WHSC1 (NSD2/MMSET) in cartilage loss of functions in OA.

Methods: We used primary human OA chondrocytes, specific siRNA interference, western-blot, transient transfection, IL-1b treatment, RT-qPCR, Elisa and statistical analysis.

Results: We found that WHSC1 mRNA expression is reduced in OA senescent-like cartilage compared to healthy donors. WHSC1 mRNA and protein levels are as well reduced in human primary chondrocytes following IL-1b chronic treatment. By a loss of function experiment based on specific siRNA against WHSC1, we found an up-regulation of MMP1, MMP13 and ADAMTS5 mRNA accumulation but not pro-inflammatory cytokines (IL-8, IL-6) in primary chondrocytes. As result, WHSC1-depleted chondrocytes show a reduced expression in Aggrecan and a slight increase production in GAG.

Conclusion:

Our preliminary data demonstrate that WHSC1 impacts articular homeostasis maintenance by repressing part of the senescence-associated secretome induced in OA. Further experiments are required in particular for understanding how WHSC1-dependent epigenetic regulation of these hypertrophic-associated matrix-remodeling factors, occurs.


Disclosure:

F. Espinoza,
None;

Y. M. Pers,
None;

P. Chuchana,
None;

J. M. Brondello,
None;

C. Jorgensen,
None.

  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

« Back to ACR/ARHP Annual Meeting 2013

ACR Meeting Abstracts - https://acrabstracts.org/abstract/repression-of-wolf-hischhorn-syndrome-candidate-1-whsc1-contributes-to-the-osteoarthritis-inducing-cartilage-loss-of-functions/

Advanced Search

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology